Viewing Study NCT03793166


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2025-12-25 @ 2:24 PM
Study NCT ID: NCT03793166
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-17
First Post: 2019-01-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module